ANITA FREHE, ZUIDHORN, GRONINGEN
Anita was diagnosed with breast cancer in 2006 - 11 years ago. In 2013, the cancer metastasized to her bones. Part of her treatment was a medicine called Pertuzumab, which a pharmaceutical company is now charging an estimated €54,000 per year to access.
ERNST KUIPERS, Chairman of the Board of Directors,
Erasmus Medical Center, ROTTERDAM
Prof. dr. Ernst Kuipers wants to see many more new medicines become available, but worries that high prices are making them unaffordable and inaccessible for patients.
DR TIM REED, DIRECTOR OF HEALTH ACTION INTERNATIONAL, AMSTERDAM
"What we're seeing in The Netherlands is a reflection of what's happening around the world—high prices, no transparency and no recognition of the fact that taxpayers already contribute significant amounts to researching new medicines."
© Mark Henley, Panos Pictures
What's your story?
Share it with us by commenting below.